Tramadol and sufentanil treatment in controlled analgesia after cesarean section Pharmacoeconomic Evaluation

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16008261

Enrollment

Unknown

Registered

2016-04-11

Start date

2016-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean section

Interventions

test group:Use of tramadol hydrochloride controlled analgesia

controlled group:Use of sufentanil controlled analgesia

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. single fetus, full-term pregnancy; 2. ASA I-II grade; 3. aged 20 to 40 years old; 4. Maternity pregnant women with no disease, history of mental disorders, chronic pain history, history of drugs and drug addiction; 5. The voluntary signing of cesarean section and patient-controlled intravenous analgesia informed consent form; 6. Within one hour operation time, blood loss is expected <=200ml; 7. If the first child for the cesarean section, the second child in 3 years after cesarean section, cut the current unified clinical widely used transverse incision prevail; 8. anesthesia: to block the plane reached T6, subject to no more than T4; 9. Other indications for cesarean section in line with.

Exclusion criteria

Exclusion criteria: 1. The combined heart, brain, liver, kidney and hematopoietic system and other serious diseases; 2. obese patients (BMI index >=25); 3. have allergies and opioids, tramadol allergy; 4. Long-term use of alcohol, analgesics, opioids and opiate addicts; 5. having respiratory insufficiency, upper respiratory tract is not smooth, sleep apnea, circulatory instability and 6. Analgesic Drug Application contraindications; 7. With neurological, psychiatric, language dysfunction can not be pain assessor; 8. placenta previa cases by B ultrasound diagnosis; 9. anesthesia puncture who appear paresthesia; 10. The spinal anesthesia dosage <=3ml (0.66% hyperbaric ropivacaine solution) (administered by individual differences); 11. emergency cesarean section patients not included in (Note emergency cesarean section may not be included in the exclusion criteria); 12. Researchers consider it appropriate to study patients.

Design outcomes

Primary

Measure	Time frame
Scores;Vomit;Scores;	—

Secondary

Measure	Time frame
Scores;Scores;	—

Countries

China

Contacts

Public ContactHu Ming

West China School of Pharmacy Sichuan University

huming@scu.edu.cn+86 028-85501387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026